Caraglia M - Search Results

1

Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients.

Correale P, Botta C, Basile A, Pagliuchi M, Licchetta A, Martellucci I, Bestoso E, Apollinari S, Addeo R, Misso G, Romano O, Abbruzzese A, Lamberti M, Luzzi L, Gotti G, Rotundo MS, Caraglia M, Tagliaferri P. Correale P, et al. Among authors: caraglia m. Cancer Biol Ther. 2011 Jul 15;12(2):112-8. doi: 10.4161/cbt.12.2.15722. Epub 2011 Jul 15. Cancer Biol Ther. 2011. PMID: 21525780 Free article. Clinical Trial.

2

5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells.

Caraglia M, Pinto A, Correale P, Zagonel V, Genua G, Leardi A, Pepe S, Bianco AR, Tagliaferri P. Caraglia M, et al. Ann Oncol. 1994 Mar;5(3):269-76. doi: 10.1093/oxfordjournals.annonc.a058806. Ann Oncol. 1994. PMID: 7514437 Free article.

3

alpha-Interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells.

Caraglia M, Leardi A, Corradino S, Ciardiello F, Budillon A, Guarrasi R, Bianco AR, Tagliaferri P. Caraglia M, et al. Int J Cancer. 1995 May 4;61(3):342-7. doi: 10.1002/ijc.2910610312. Int J Cancer. 1995. PMID: 7729946

4

Cytosine arabinoside (Ara-C) plus alpha-interferon (alpha IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimens.

Palmieri G, Morabito A, Rea A, Caraglia M, Tagliaferri P, Bianco AR. Palmieri G, et al. Among authors: caraglia m. Br J Haematol. 1994 Oct;88(2):421-3. doi: 10.1111/j.1365-2141.1994.tb05046.x. Br J Haematol. 1994. PMID: 7803297 Clinical Trial.

5

Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy.

Tagliaferri P, Caraglia M, Muraro R, Pinto A, Budillon A, Zagonel V, Bianco AR. Tagliaferri P, et al. Among authors: caraglia m. Anticancer Drugs. 1994 Aug;5(4):379-93. doi: 10.1097/00001813-199408000-00001. Anticancer Drugs. 1994. PMID: 7949241 Review.

6

Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR. Caraglia M, et al. Cancer Immunol Immunother. 1993 Aug;37(3):150-6. doi: 10.1007/BF01525428. Cancer Immunol Immunother. 1993. PMID: 8392910 Free PMC article.

7

Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation.

Correale P, Tagliaferri P, Guarrasi R, Caraglia M, Giuliano M, Marinetti MR, Bianco AR, Procopio A. Correale P, et al. Among authors: caraglia m. Immunol Lett. 1997 Feb;55(2):69-78. doi: 10.1016/s0165-2478(96)02687-9. Immunol Lett. 1997. PMID: 9143936

8

Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells.

Caraglia M, Passeggio A, Beninati S, Leardi A, Nicolini L, Improta S, Pinto A, Bianco AR, Tagliaferri P, Abbruzzese A. Caraglia M, et al. Biochem J. 1997 Jun 15;324 ( Pt 3)(Pt 3):737-41. doi: 10.1042/bj3240737. Biochem J. 1997. PMID: 9210396 Free PMC article.

9

Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects.

Tagliaferri P, Barile C, Caraglia M, Guarrasi R, Morelli D, Ricciardi B, Martignetti A, Librera MT, Matano E, Della Vecchia A, Catalano G, Famiani M, Palmieri G, Correale P, Bianco AR. Tagliaferri P, et al. Among authors: caraglia m. Am J Clin Oncol. 1998 Feb;21(1):48-53. doi: 10.1097/00000421-199802000-00011. Am J Clin Oncol. 1998. PMID: 9499257 Clinical Trial.

10

Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications.

Tagliaferri P, Guarrasi R, Caraglia M, Morelli D, Fabbrocini A, Correale P, Bianco AR. Tagliaferri P, et al. Among authors: caraglia m. Cancer Immunol Immunother. 1998 May;46(3):121-7. doi: 10.1007/s002620050470. Cancer Immunol Immunother. 1998. PMID: 9625535 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters